All In Biotech

Drug Trial Radar · NCT04236778

First-in-human Study of VE303 in Healthy Adult Volunteers

A Phase 1a/1b, First-in-human, Open-label Study of Escalating Doses of VE303 in Healthy Adult Volunteers With or Without Vancomycin Pre-treatment to Evaluate Safety, Dosing, and Pharmacodynamics

Last checked: Nov 19, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

39

Actual

Start

Nov 28, 2017

Primary completion

Mar 11, 2019

Study completion Mar 11, 2019

Sponsor

Lead sponsor
Vedanta Biosciences, Inc.Industry
Sponsor type
Industry
First posted
Jan 22, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study was designed to evaluate safety and tolerability of a range of doses of VE303 in healthy adult volunteers. The study also evaluated pharmacokinetics of intestinal colonization by the VE303 strains and pharmacodynamics of recovery of the gut microbiota after administration of antibiotics followed by a course of VE303.

Conditions

  • Healthy Volunteers

Interventions

  • VE303Drug

    The VE303 Drug Product is a live biotherapeutic product (LBP) consisting of 8 clonal human commensal bacterial strains manufactured under GMP conditions.

  • Oral VancomycinDrug

    Vancomycin, when taken by mouth, is used to treat Clostridium difficile-associated diarrhea.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of VE303 measured by incidence adverse events (AEs)Time frame: 12 months post-dose
  2. Tolerability of VE303 using modified PROMIS questionnaire (v1.0)Time frame: 12 months post-dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pharmaron CPC

    Baltimore, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.